Targeting Ferroptosis against Ischemia/Reperfusion Cardiac Injury
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Ischemic heart disease is a leading cause of death worldwide. Primarily, ischemia causes decreased oxygen supply, resulting in damage of the cardiac tissue. Naturally, reoxygenation has been recognized as the treatment of choice to recover blood flow through primary percutaneous coronary intervention. This treatment is the gold standard therapy to restore blood flow, but paradoxically it can also induce tissue injury. A number of different studies in animal models of acute myocardial infarction (AMI) suggest that ischemia-reperfusion injury (IRI) accounts for up to 50% of the final myocardial infarct size. Oxidative stress plays a critical role in the pathological process. Iron is an essential mineral required for a variety of vital biological functions but also has potentially toxic effects. A detrimental process induced by free iron is ferroptosis, a non-apoptotic type of programmed cell death. Accordingly, efforts to prevent ferroptosis in pathological settings have focused on the use of radical trapping antioxidants (RTAs), such as liproxstatin-1 (Lip-1). Hence, it is necessary to develop novel strategies to prevent cardiac IRI, thus improving the clinical outcome in patients with ischemic heart disease. The present review analyses the role of ferroptosis inhibition to prevent heart IRI, with special reference to Lip-1 as a promising drug in this clinicopathological context.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of nrf2 in oxidative stress and toxicity
Ma, Q. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140320 · Cited by 4,903 · cited 1×
“Nrf2 is not an antioxidant but is a transcription factor, and a key regulator of the cellular antioxidant response [131].”
BackgroundYellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Friedmann Angeli, J. P., Schneider, M., Proneth, B., Tyurina, Y. Y., Tyurin, V. A., Hammond, V. J., Herbach, N., Aichler, M., Walch, A., Eggenhofer, E., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3064 · Cited by 3,732
Ferroptosis: process and function
Xie, Y., Hou, W., Song, X., Yu, Y., Huang, J., Sun, X., Kang, R., & Tang, D. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2015.158 · Cited by 3,727
ROS as signalling molecules: Mechanisms that generate specificity in ROS homeostasis
D'Autréaux, B., & Toledano, M. B. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2256 · Cited by 3,642 · cited 1×
“The hydroxyl radical has a high reactivity and low specificity, making it a very dangerous radical, capable of attacking all classes of biological molecules to a higher rate than O2 [7,19].”
BackgroundFSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
Role of Mitochondria in Ferroptosis
Gao, M., Yi, J., Zhu, J., Minikes, A. M., Monian, P., Thompson, C. B., & Jiang, X. (2019) · Molecular Cell · doi:10.1016/j.molcel.2018.10.042 · Cited by 2,120
Glutaminolysis and transferrin regulate ferroptosis
Gao, M., Monian, P., Quadri, N., Ramasamy, R., & Jiang, X. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.06.011 · Cited by 2,069 · cited 5×
“This can be caused by both intracellular and extracellular mechanisms and there are conditions that cause the cell to be more susceptible to this type of cell death such as cysteine deprivation or low levels of GSH [103].”
BackgroundInfluentialRAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels
Yagoda, N., von Rechenberg, M., Zaganjor, E., Bauer, A. J., Yang, W. S., Fridman, D. J., Wolpaw, A. J., Smukste, I., Peltier, J. M., Boniface, J. J., et al. (2007) · Nature · doi:10.1038/nature05859 · Cited by 1,631
Cao, J. Y., & Dixon, S. J. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2194-1 · Cited by 1,515 · cited 1×
“Currently, there are two classes of ferroptosis inducers that target specific proteins in the ferroptotic pathway [77], described below.”
BackgroundSeiler, A., Schneider, M., Förster, H., Roth, S., Wirth, E. K., Culmsee, C., Plesnila, N., Kremmer, E., Rådmark, O., Wurst, W., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.07.005 · Cited by 1,470
Synchronized renal tubular cell death involves ferroptosis
Linkermann, A., Skouta, R., Himmerkus, N., Mulay, S. R., Dewitz, C., De Zen, F., Prokai, A., Zuchtriegel, G., Krombach, F., Welz, P.-S., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1415518111 · Cited by 1,126
Sindrilaru, A., Peters, T., Wieschalka, S., Baican, C., Baican, A., Peter, H., Hainzl, A., Schatz, S., Qi, Y., Schlecht, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44490 · Cited by 1,100 · cited 5×
“Additionally, in some situations such as inflammatory processes, formation of O2•− and NO• occurs, thus triggering the production of ONOO−, a potent oxidizing molecule that can cause DNA fragmentation or lipid oxidation [13,14].”
BackgroundInfluentialBrand, M. D. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.04.001 · Cited by 1,063
Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease
Haeggström, J. Z., & Funk, C. D. (2011) · Chemical Reviews · doi:10.1021/cr200246d · Cited by 875 · cited 1×
“LOXs are iron-containing enzymes that catalyze polyunsaturated fatty acid (PUFA) dioxygenation, thus producing lipid hydroperoxides that accumulate in RE [73,74].”
BackgroundCurrent understanding of iron homeostasis
Anderson, G. J., & Frazer, D. M. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.155804 · Cited by 688
Toward clinical application of the Keap1-Nrf2 pathway
Suzuki, T., Motohashi, H., & Yamamoto, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.005 · Cited by 680 · cited 1×
“On the other hand, the protective role of Nfr2, under oxidative stress, is that it plays a role in the protection of our body against stress-induced diseases because it activates several pathways that include nuclear translocation and recruitment of transcriptional coactivators, resulting in the binding between Nrf2 a…”
BackgroundSiscovick, D. S., Barringer, T. A., Fretts, A. M., Wu, J. H. Y., Lichtenstein, A. H., Costello, R. B., Kris-Etherton, P. M., Jacobson, T. A., Engler, M. B., Alger, H. M., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000482 · Cited by 629 · cited 1×
“Concomitantly with IRI, a lipid metabolism disorder occurs in organs such as the heart [126].”
BackgroundKim, S. E., Zhang, L., Ma, K., Riegman, M., Chen, F., Ingold, I., Conrad, M., Turker, M. Z., Gao, M., Jiang, X., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.164 · Cited by 622
The ATP synthase: the understood, the uncertain and the unknown
Walker, J. E. (2013) · Biochemical Society Transactions · doi:10.1042/bst20110773 · Cited by 614
Ferroptosis Inhibition: Mechanisms and Opportunities
Angeli, J. P. F., Shah, R., Pratt, D. A., & Conrad, M. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.02.005 · Cited by 563
Regulated cell death and inflammation: an auto-amplification loop causes organ failure
Linkermann, A., Stockwell, B. R., Krautwald, S., & Anders, H.-J. (2014) · Nature Reviews Immunology · doi:10.1038/nri3743 · Cited by 522 · cited 1×
“The evidence of necroinflammation and its relationship with ferroptosis is very poor and much remains to be investigated [92] but recent studies show that ferroptotic cells collapse and release molecular mediators associated with pro-inflammatory damage [93].”
BackgroundThe role of oxidative stress in the pathophysiology of hypertension
Rodrigo, R., González, J., & Paoletto, F. (2011) · Hypertension Research · doi:10.1038/hr.2010.264 · Cited by 436 · cited 1×
“Oxidative stress is a pathogenetic mechanism based on an imbalance between production of ROS over the antioxidant defense system in the body and the loss of control over redox signaling events within the cells [10,11].”
BackgroundDie another way – non-apoptotic mechanisms of cell death
Tait, S. W. G., Ichim, G., & Green, D. R. (2014) · Journal of Cell Science · doi:10.1242/jcs.093575 · Cited by 366 · cited 1×
“This cell death pathway, unlike other cell death pathways such as apoptosis, does not present a silent inflammatory response [91].”
BackgroundSrikantan, S. (2012) · Frontiers in Bioscience · doi:10.2741/3921 · Cited by 353 · cited 1×
“Embryonic lethal-abnormal vision like protein1 (ELAVL1) is a protein coding gene that regulates gene expression by stabilizing message RNAs such as TNF-α or VEGF-A and is related to the process of cell death and oxidative stress [86].”
BackgroundThe Pharmacokinetics of Vitamin C
Lykkesfeldt, J., & Tveden-Nyborg, P. (2019) · Nutrients · doi:10.3390/nu11102412 · Cited by 344 · cited 1×
“Effects dependent on its route of administration and the concentration of AA given to patients have been described [123], where Davis et al.”
BackgroundQuinlan, C. L., Goncalves, R. L. S., Hey-Mogensen, M., Yadava, N., Bunik, V. I., & Brand, M. D. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.545301 · Cited by 310 · cited 1×
“Furthermore, the site that generates more ROS in the mitochondria is commonly associated with complex I, while this actually corresponds to 2-oxoglutarate dehydrogenase complex (Of), which generates eight times more superoxide/hydrogen peroxide than site If in skeletal muscle mitochondria under optimum conditions [16].”
BackgroundKim, J.-S., Jin, Y., & Lemasters, J. J. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00683.2005 · Cited by 310
Chen, Q., Moghaddas, S., Hoppel, C. L., & Lesnefsky, E. J. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00211.2007 · Cited by 299
VÁSQUEZ-VIVAR, J., MARTÁSEK, P., WHITSETT, J., JOSEPH, J., & KALYANARAMAN, B. (2002) · Biochemical Journal · doi:10.1042/bj3620733 · Cited by 287 · cited 2×
“itric oxide is f r e fr t e rsi f - r i i e t - itr li e , t d ri car i c isc i , tetr , i i i , c i to prod ce large a ounts of superoxide during reperfusion instead of nitric oxide [35,39].”
BackgroundCardioprotective and Antiapoptotic Effects of Heme Oxygenase-1 in the Failing Heart
Wang, G., Hamid, T., Keith, R. J., Zhou, G., Partridge, C. R., Xiang, X., Kingery, J. R., Lewis, R. K., Li, Q., Rokosh, D. G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.905471 · Cited by 249 · cited 1×
“Moreover, this study shows that HO-1 overexpression attenuates hypertrophy, fibrosis, and oxidant stress, and also promotes neovascularization in the failing heart [136].”
BackgroundmTOR regulates cellular iron homeostasis through tristetraprolin
Bayeva, M., Khechaduri, A., Puig, S., Chang, H.-C., Patial, S., Blackshear, P. J., & Ardehali, H. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.001 · Cited by 197
Clinical pharmacology and therapeutic use of antioxidant vitamins
Rodrigo, R., Guichard, C., & Charles, R. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2006.00466.x · Cited by 124 · cited 1×
“ROS are formed either by enzymatic or non-enzymatic production in mammalian cells as intermediates of the reduction of oxygen molecules to water during cellular metabolism, such as superoxide (O2), hydrogen peroxide (H2O2) and hydroxyl radical (•OH) [12].”
BackgroundSelf-citationJang, S., Lewis, T. S., Powers, C., Khuchua, Z., Baines, C. P., Wipf, P., & Javadov, S. (2017) · Antioxidants & Redox Signaling · doi:10.1089/ars.2016.6635 · Cited by 103 · cited 1×
“In some cases, XJB-5-131 effects have been evaluated on cardiac tissue subjected to IRI in rats, enhancing cardiac tolerance to oxidative stress, improving post-ischemic recovery of cardiac function and inhibiting PTP opening [156,157].”
Huang, J., Weinstein, S. J., Yu, K., Männistö, S., & Albanes, D. (2019) · Circulation Research · doi:10.1161/circresaha.119.314944 · Cited by 79 · cited 1×
“This corresponds to an important agent in the prevention of cardiovascular diseases, where a recent study reported that higher α-TOH baseline serum concentration is associated with a decreased risk overall and causes specific mortality for cardiovascular and heart diseases among several other disease groups [118].”
Cited by
Pitz Jacobsen, D., Fjeldstad, H. E., Johnsen, G. M., Fosheim, I. K., Moe, K., Alnæs-Katjavivi, P., Dechend, R., Sugulle, M., & Staff, A. C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.791606 · Cited by 36
Metadata
- Authors
- Lillo-Moya, J., Rojas-Solé, C., Muñoz-Salamanca, D., Panieri, E., Saso, L., & Rodrigo, R.
- Venue
- Antioxidants
- Publisher
- MDPI AG
- Published
- 2021-04-25
- Volume
- 10
- Issue
- 5
- Pages
- 667
- ISSN
- 2076-3921 (ISSN-L)
- OpenAlex
- W3158061511
- Cited by
- 159
- References
- 35
- FWCI
- 17.02
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.